Novel Aza-analogous Ergoline Derived Scaffolds as Potent Serotonin 5-HT₆ and Dopamine D₂ Receptor Ligands.

Novel Aza-analogous Ergoline Derived Scaffolds as Potent Serotonin 5-HT₆ and Dopamine D₂ Receptor Ligands. Medicinal Chemistry Driven Approaches Toward Novel and Selective Serotonin 5-HT₆Receptor Ligands 5-Cyclic Amine-3-arylsulfonylindazoles as Novel 5-HT₆ Receptor Antagonists The biogenic amine transporter activity of vinylogous amphetamine analogs Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles 2-Substituted Tryptamines:  Agents with Selectivity for 5-HT₆Serotonin Receptors Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia Structure-activity relationships of N-substituted dopamine and 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene analogs: behavioral effects in lesioned and reserpinized mice Discovery of Highly Potent Serotonin 5-HT₂ Receptor Agonists Inspired by Heteroyohimbine Natural Products The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds